News
EULAR now recommends moving directly to biologic or targeted synthetic disease-modifying antirheumatic drugs if the initial ...
GLP-1 receptor agonists may significantly reduce the risk for cardiovascular events in patients with rheumatoid arthritis ...
Rheumatoid arthritis is a painful and disabling autoimmune disease that affects more than 1% of people worldwide. In the ...
10d
MedPage Today on MSNFirst-Line Anti-TNFs Keep Rheumatoid Arthritis Manageable Long-TermSustained remission at 10 years was more common as well among the patients starting anti-TNFs right away, Toyoda told ...
8d
MedPage Today on MSNGood News, Mostly, on Preventing Rheumatoid ArthritisAggressive treatment for patients who look like they may soon develop rheumatoid arthritis (RA) appears very effective for ...
A population-based cross-sectional study published in Clinical Rheumatology reveals that individuals with rheumatoid ...
A recent study discovered an exponential rise in rheumatoid arthritis all across the globe.Researchers found that the ...
Among patients with mNSCLC receiving ICIs, overall survival was similar between those with vs without coexisting RA.
Tocilizumab alone and in combination with methotrexate outperformed the latter drug in patients who did not adequately ...
8d
MedPage Today on MSNZap the Skull to Treat Rheumatoid Arthritis Pain?BARCELONA -- Rheumatoid arthritis (RA) patients saw significant reductions in pain with transcranial direct current ...
Sleep disturbances have been identified to significantly compromise pain interference in early rheumatoid arthritis (RA) ...
I am writing to express my deep concern regarding the recent announcement that the CHI Arthritis and Rheumatology will be closing its doors. As a member of the community who has benefitted greatly ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results